Patents Assigned to Selamine Limited
  • Publication number: 20120035138
    Abstract: A bisphosphonate is formulated with an agent to reduce surface tension and/or reduce foaming in the stomach, leading to reduced reflux and oesophageal irritation in use and increased patient compliance.
    Type: Application
    Filed: October 13, 2011
    Publication date: February 9, 2012
    Applicant: SELAMINE LIMITED
    Inventors: Paul Jonathan Harrison, Anna Marie Power
  • Patent number: 8093228
    Abstract: A bisphosphonate is formulated with an agent to reduce surface tension and/or reduce foaming in the stomach, leading to reduced reflux and oesophageal irritation in use and increased patient compliance.
    Type: Grant
    Filed: October 31, 2008
    Date of Patent: January 10, 2012
    Assignee: Selamine Limited
    Inventors: Paul Jonathan Harrison, Anna Marie Power
  • Publication number: 20090053162
    Abstract: A bisphosphonate is formulated with an agent to reduce surface tension and/or reduce foaming in the stomach, leading to reduced reflux and oesophageal irritation in use and increased patient compliance.
    Type: Application
    Filed: October 31, 2008
    Publication date: February 26, 2009
    Applicant: Selamine Limited
    Inventors: Paul Jonathan Harrison, Anna Marie Power
  • Patent number: 7473684
    Abstract: A bisphosphonate for treatment of osteoporosis is formulated with an amount of an antifoaming agent effective for reducing foaming in the stomach, leading to reduced reflux and oesophageal irritation in use and increased patient compliance.
    Type: Grant
    Filed: May 24, 2006
    Date of Patent: January 6, 2009
    Assignee: Selamine Limited
    Inventors: Paul Jonathan Harrison, Anna Marie Power
  • Publication number: 20080188539
    Abstract: The present invention relates to ramipril-amino acid salts, such as, naturally occurring, basic amino acid salts of ramipril.
    Type: Application
    Filed: November 30, 2007
    Publication date: August 7, 2008
    Applicant: Selamine Limited
    Inventors: Paul Jonathan Harrison, Anna Marie Elizabeth Power, Deirdre O'Keeffe
  • Publication number: 20080171775
    Abstract: The present invention relates to a ramipril-amlodipine salt.
    Type: Application
    Filed: November 30, 2007
    Publication date: July 17, 2008
    Applicant: Selamine Limited
    Inventors: Paul Jonathan Harrison, Anna Marie Elizabeth Power, Deirdre O'Keeffe
  • Publication number: 20080167364
    Abstract: The present invention relates to ramipril-amine salts, such as, primary, secondary, tertiary and quaternary salts of ramipril.
    Type: Application
    Filed: November 30, 2007
    Publication date: July 10, 2008
    Applicant: Selamine Limited
    Inventors: Paul Jonathan Harrison, Anna Marie Elizabeth Power, Deirdre O'Keeffe
  • Publication number: 20080108688
    Abstract: A Ramipril formulation which is suitably stabilised to control the degradation to the active metabolite ramiprilat.
    Type: Application
    Filed: October 29, 2007
    Publication date: May 8, 2008
    Applicant: Selamine Limited
    Inventors: Paul Harrison, Anna Power
  • Publication number: 20080108687
    Abstract: A Ramipril formulation which is suitably stabilised to control the degradation to the active metabolite ramiprilat.
    Type: Application
    Filed: October 29, 2007
    Publication date: May 8, 2008
    Applicant: Selamine Limited
    Inventors: Paul Harrison, Anna Power
  • Publication number: 20070259941
    Abstract: A Ramipril formulation which is suitably stabilised to control the degradation to the active metabolite ramiprilat.
    Type: Application
    Filed: November 15, 2005
    Publication date: November 8, 2007
    Applicant: Selamine Limited
    Inventors: Paul Harrison, Anna Power
  • Publication number: 20070098782
    Abstract: A Ramipril formulation which is suitably stabilised to control the degradation to the active metabolite ramiprilat.
    Type: Application
    Filed: August 24, 2006
    Publication date: May 3, 2007
    Applicant: Selamine Limited
    Inventors: Paul Harrison, Anna Power
  • Publication number: 20070065507
    Abstract: A bisphosphonate for treatment of osteoporosis is formulated with an amount of an antifoaming agent effective for reducing foaming in the stomach, leading to reduced reflux and oesophageal irritation in use and increased patient compliance.
    Type: Application
    Filed: May 24, 2006
    Publication date: March 22, 2007
    Applicant: Selamine LImited
    Inventors: Paul Harrison, Anna Power
  • Publication number: 20070053975
    Abstract: A Ramipril formulation rapidly disintegrates after ingestion and exhibits substantially no food effect.
    Type: Application
    Filed: August 24, 2006
    Publication date: March 8, 2007
    Applicant: Selamine Limited
    Inventors: Paul Harrison, Anna Power